Literature DB >> 30310672

Genoprotective effects of gallic acid against cisplatin induced genotoxicity in bone marrow cells of mice.

S Shruthi1, K Bhasker Shenoy2.   

Abstract

Chemotherapeutic drugs are used for the treatment of cancer. However, the use of these drugs is limited due to their side effects on normal cells. One of the measures to detect chemoprotection of plant extracts is to evaluate their anticlastogenic effects. In this study, we report the anticlastogenic effect of gallic acid (GA) against cisplatin (Csp), a chemotherapeutic drug, in Swiss albino mice. Three different doses of GA (100, 200 and 400 mg per kg bw) were administered orally to the experimental animals in 0.2 mL quantity for 5 days at 24 hour intervals. Cisplatin, the positive control agent (10 mg per kg bw), was administered intraperitoneally (i.p.) in 0.1 mL quantity. Overall, the results showed that the pretreatment of GA caused a remarkable decrease in Csp induced micronucleus frequency and DNA damage in bone marrow cells of mice. The results suggest that GA showed potent antigenotoxic effects against Csp induced damage in mice bone marrow cells.

Entities:  

Year:  2018        PMID: 30310672      PMCID: PMC6116806          DOI: 10.1039/c8tx00058a

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  21 in total

1.  Inter-laboratory comparison of the in vivo comet assay including three image analysis systems.

Authors:  Ulla Plappert-Helbig; Melanie Guérard
Journal:  Environ Mol Mutagen       Date:  2015-08-06       Impact factor: 3.216

2.  [Chemical mutagenesis in mammals. The Chinese hamster bone marrow as an in vivo test system. Hematological findings after treatment with trenimon].

Authors:  K Boller; W Schmid
Journal:  Humangenetik       Date:  1970

3.  An evaluation, using the comet assay and the micronucleus test, of the antigenotoxic effects of chlorophyll b in mice.

Authors:  Juliana Mara Serpeloni; Denise Grotto; Alexandre Ferro Aissa; Adriana Zerlotti Mercadante; Maria de Lourdes Pires Bianchi; Lusânia Maria Greggi Antunes
Journal:  Mutat Res       Date:  2011-07-06       Impact factor: 2.433

4.  Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy.

Authors:  Stephen D Dertinger; Svetlana L Avlasevich; Dorothea K Torous; Jeffrey C Bemis; Souk Phonethepswath; Carson Labash; Kristine Carlson; Jared Mereness; John Cottom; James Palis; James T MacGregor
Journal:  Toxicol Sci       Date:  2014-05-05       Impact factor: 4.849

Review 5.  Recognition and repair of DNA-cisplatin adducts.

Authors:  Katarzyna Woźniak; Janusz Błasiak
Journal:  Acta Biochim Pol       Date:  2002       Impact factor: 2.149

6.  Results of the International Validation of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens: Individual data for 1,2-dibromoethane, p-anisidine, and o-anthranilic acid in the 2nd step of the 4th phase Validation Study under the JaCVAM initiative.

Authors:  Hironao Takasawa; Rie Takashima; Kazunori Narumi; Kazufumi Kawasako; Akiko Hattori; Masayoshi Kawabata; Shuichi Hamada
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2015-03-05       Impact factor: 2.873

7.  Comet assay evaluation of six chemicals of known genotoxic potential in rats.

Authors:  Cheryl A Hobbs; Leslie Recio; Michael Streicker; Molly H Boyle; Jin Tanaka; Atsushi Shiga; Kristine L Witt
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2015-03-07       Impact factor: 2.873

Review 8.  Particular aspects of platinum compounds used at present in cancer treatment.

Authors:  Bernard Desoize; Claudie Madoulet
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

9.  Gardenia jasminoides extracts and gallic acid inhibit lipopolysaccharide-induced inflammation by suppression of JNK2/1 signaling pathways in BV-2 cells.

Authors:  Wen-Hung Lin; Heng-Hung Kuo; Li-Hsing Ho; Ming-Lang Tseng; An-Ci Siao; Chang-Tsen Hung; Kee-Ching Jeng; Chien-Wei Hou
Journal:  Iran J Basic Med Sci       Date:  2015-06       Impact factor: 2.699

10.  Micronuclei in genotoxicity assessment: from genetics to epigenetics and beyond.

Authors:  Lidiya Luzhna; Palak Kathiria; Olga Kovalchuk
Journal:  Front Genet       Date:  2013-07-11       Impact factor: 4.599

View more
  4 in total

1.  Protective Effect of Silymarin and Gallic Acid against Cisplatin-Induced Nephrotoxicity and Hepatotoxicity.

Authors:  Duygu Doğan; İsmet Meydan; Ahmet Ufuk Kömüroğlu
Journal:  Int J Clin Pract       Date:  2022-04-16       Impact factor: 3.149

2.  Synergistic induction of apoptosis in a cell model of human leukemia K562 by nitroglycerine and valproic acid.

Authors:  Shahin Aalaei; Mehdi Mohammadzadeh; Yaghub Pazhang
Journal:  EXCLI J       Date:  2019-08-15       Impact factor: 4.068

3.  A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo.

Authors:  Fairouz Sioud; Souheila Amor; Imène Ben Toumia; Aida Lahmar; Virginie Aires; Leila Chekir-Ghedira; Dominique Delmas
Journal:  Cells       Date:  2020-02-04       Impact factor: 6.600

4.  Xanthohumol, a Prenylated Flavonoid from Hops, Induces DNA Damages in Colorectal Cancer Cells and Sensitizes SW480 Cells to the SN38 Chemotherapeutic Agent.

Authors:  Alessandra Scagliarini; Aline Mathey; Virginie Aires; Dominique Delmas
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.